期刊文献+

多索茶碱、洛贝林、尼克刹米、甲泼尼龙琥珀酸钠注射剂配伍稳定性研究 被引量:2

Stability of Doxofylline Injection, Nikethamide Injection,Lobeline Injection and Methylprednisolone Sodium Succinate for Injection in Compatibility Solutions
下载PDF
导出
摘要 目的:考查多索茶碱、尼克刹米、洛贝林、甲泼尼龙琥珀酸钠注射剂的配伍稳定性。方法:观察及测定4种注射剂在5%葡萄糖氯化钠注射液和0.9%氯化钠注射液中配伍后室温放置8 h内的外观、不溶性微粒及pH。采用HPLC法测定配伍液室温放置8 h内的含量变化。结果:与配伍0h比较,配伍液放置8 h内的外观色泽、不溶性微粒及含量均无明显变化,pH略有变化。配伍液中各药含量在8 h内保持在90%以上,且配伍8 h内无新物质产生。结论:多索茶碱、尼克刹米、洛贝林、甲泼尼龙琥珀酸钠注射剂在5%葡萄糖氯化钠注射液和0.9%氯化钠注射液中配伍后于室温放置8 h内质量基本稳定。 Objective : To study the compatible stability of Doxofylline for Injection, Nikethamide injection, Lobeline Hydrochoride injection and methylprednisolone sodium succinate for Injection. Method: The changes in appearance, particles and pH of the mixture of the four injections in 5% glucose and sodium chloride injection and 0.9% sodium chloride injection within 8 hours at ambient temperature were observed, the concentrations of the mixture of the four injections in 5% glucose and sodium chloride injection and'0.9% sodium chloride injection were determined by HPLC within 8 hours. Result: Compared with the solutions at Oh of mixing, no signifi- cant changes were noted in color, clarity, particles and concentration within 8 hours mixing. However, there were a few changes in their pH values. Conclusion: The mixture of doxofylline for Injection, nikethamide injection, lobeline hydrochoride injection and methylprednisolone sodium succinate for injection in 5% glucose and sodium chloride injection and 0.9% sodium chloride injection is stable in quality within 8 hours mixing at ambient temperature.
出处 《中国药师》 CAS 2008年第3期310-313,共4页 China Pharmacist
关键词 多索茶碱 尼克刹米 洛贝林 甲泼尼龙琥珀酸钠 配伍 稳定性 Doxofylline Nikethamide Lobeline Methylprednisolone sodium succinate Compatibilitiy
  • 相关文献

参考文献10

二级参考文献29

  • 1薛闻鹏 钟帼英.头孢呋辛在输液中的稳定性研究[J].白求恩医科大学学报,1999,3(8):95-95.
  • 2张丽艳 王朝营 等.清开灵及黄芪注射液在两种输液中的微粒观察[J].中国医院药学杂志,2001,(5):315-315.
  • 3Ychou M, Duffour J, Kramar A, et al. Individual 5-FU dose adaptation in metastatic colorec cancer:results of a phase Ⅱ study using a bimonthly pharmacokinetically intensified LV5FU2 regime[J] . Cancer Chemother Pharmacol, 2003,52(4):282-290.
  • 4Lombardi D, Di L V, Piani B, et al. Acceptance of exter-nal infusion pumps in patients with advanced breast cancer receiving continuous infusion fluorouracil [J] . Tumori, 2003,89(5):488-491.
  • 5Lawrence T S,Blackstock A W,Ncginn C.The mechanism of action of radiosensitization of conventional chemothera-peutic agents[J].Semin Radiat Oncol,2003,13(1):13-21.
  • 6中华人民共和国卫生部药典委员会.中华人民共和国药典[s].北京:化学工业出版社,2000.75.
  • 7国家药典委员会.中华人民共和国药典(二部)[Z].北京:化学工业出版社,2000.附录69-70.
  • 8徐朝阳,刘波.一次性使用注射器、输液器灭菌效果监测分析[J].中华医院感染学杂志,1997,7(1):38-39. 被引量:39
  • 9张梅芬.黄芪注射液与输液配伍的稳定性考察[J].上海医药,1997(4):29-30. 被引量:4
  • 10顾春英,薛广波.细菌对消毒剂的抗性研究进展[J].中华医院感染学杂志,1997,7(4):252-256. 被引量:46

共引文献501

同被引文献9

  • 1张莹,白海娇,李海生.HPLC法测定注射用氢化可的松琥珀酸钠中的有关物质[J].药物分析杂志,2007,27(4):607-609. 被引量:4
  • 2Nassif EG, Weinberger M, Thompson R, et al. The value of maintenance theo- phylline in steroid-dependent asthma [ J ]. New England Journal of Medicine, 1981,304:71-75.
  • 3Jonsson S, Kjartansson G, Gtslason D ,et al. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophyUlne [ J ]. Chest, 1988,94 (4) :723-726.
  • 4Cosio BG, Tsaprouni L, ho K, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages[ ] ]. J Exp Med ,2004,200 (5) :689-695.
  • 5Johnson CE, Cohen IA, Craft DA, Lizer MH. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures [ J ]. Am J Hosp Pharm, 1986,43 (6) : 1482-1485.
  • 6ZHANGXIANG-ming(张祥民).Modern Chromatograhy Analysis(现代色谱分析).Shanghai(上海):Fudan Press(复旦大学出版社),2006.75.
  • 7HUHong-wen(胡宏纹).Organic Chemistry(有机化学).Beijing(北京):High Education Press(高等教育出版社),1979.434.
  • 8SUNYU-qing(孙毓庆),HUYu-zhu(胡育筑).Selection and Op-timization of LC Solution System (液相色谱溶剂系统的选择和优化).Beijing(北京):Chemical Industry Press(化学工业出版社),2007.43.
  • 9殷勤红,朱艳琴,冯朴纯.高效液相色谱法测定注射用氢化可的松琥珀酸钠含量的色谱条件考察[J].光谱实验室,2010,27(6):2246-2249. 被引量:4

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部